Evidence map›Paper›PMID 23531101›Full record

ArticleBMC research notes2013

Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities.

Yves Henrotin, Xavier Chevalier, Gabriel Herrero-Beaumont, Timothy McAlindon, Ali Mobasheri, Karel Pavelka, Christiane Schön, Harrie Weinans, Hans Biesalski, Participants at the Hohenheim Consensus Conference in August 29th 2011

Open access · goldAbstract read
In one paragraph

Article in BMC research notes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Marine drugs · 2019
    Article
  9. Article
  10. Glucosamine Hydrochloride andTissue engineering and regenerative medicine · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 7 countries.

Yves HenrotinBone and Cartilage Research Unit, University of Liège, Institute of Pathology, Level +5, CHU Sart-Tilman, Liège, 4000, Belgium. yhenrotin@ulg.ac.be
Xavier Chevalier
Gabriel Herrero-Beaumont
Timothy McAlindon
Ali Mobasheri
Karel Pavelka
Christiane Schön
Harrie Weinans
Hans Biesalski
Participants at the Hohenheim Consensus Conference in August 29th 2011
Tufts Medical Center · USUniversity of Liège · BEUtrecht University · NLErasmus MC · NLHospital Universitario Fundación Jiménez Díaz · ESUniversity of Nottingham · GB

Funding

Biotechnology and Biological Sciences Research Council BB/G018030/1Biotechnology and Biological Sciences Research Council BBSRC/S/M/2006/13141Wellcome Trust
6 · The paper itself

Abstract

The aim of this paper was to provide an overview of the current knowledge and understanding of the potential beneficial physiological effects of glucosamine (GlcN) on joint health. The objective was to reach a consensus on four critical questions and to provide recommendations for future research priorities. To this end, nine scientists from Europe and the United States were selected according to their expertise in this particular field and were invited to participate in the Hohenheim conference held in August 2011. Each expert was asked to address a question that had previously been posed by the chairman of the conference. Based on a systematic review of the literature and the collection of recent data, the experts documented the effects of GlcN on cartilage ageing, metabolic/kinetic and maintenance of joint health as well as reduction of risk of OA development. After extensive debate and discussion the expert panel addressed each question and a general consensus statement was developed, agreeing on the current state-of-the-art and future areas for basic and clinical studies. This paper summarizes the available evidence for beneficial effects of GlcN on joint health and proposes new insight into the design of future clinical trials aimed at identifying beneficial physiological effect of GlcN on joint tissues.

Indexed as

AgingCartilageChondrocytesConsensusDietary SupplementsEuropeGlucosamineGlucoseHumansJointsOsteoarthritisRisk FactorsUnited StatesGlucosamineGlucose

Identifiers

PMID23531101
PMCPMC3629992
OpenAlexW2138376002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.